Literature DB >> 26553747

Sequential brief neuropsychological evaluation of migraineurs is identical to controls.

R Gil-Gouveia1,2, A G Oliveira3, I P Martins1.   

Abstract

BACKGROUND: Evidence of attack-related cognitive dysfunction in migraine is growing. Controversy exists on whether cognitive dysfunction, mainly executive, may persist between attacks. Measuring the impact of cognitive function is gaining importance in clinical and research settings in migraine.
OBJECTIVE: To compare the performance of interictal migraine patients to controls in an assembled neuropsychological battery focused on executive functions and to study the practice effect of its repeated applications.
METHOD: Assembly of the battery that was then applied twice within 6 weeks to interictal migraineurs and matched healthy controls.
RESULTS: Migraine patients (n = 24) and controls (n = 24) had similar performance in both applications of the battery. There was a slight practice effect between the first and second evaluation, significant in Stroop Interference test (P = 0.002, multiplicity corrected); a meaningful score change was determined for each raw test scores.
CONCLUSIONS: Interictal migraineurs and controls performance is identical in a brief cognitive battery focused on executive functions. Repeated applications produced a practice effect that was quantified.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cognitive symptoms; executive dysfunction; migraine; neuropsychological testing; practice effect

Mesh:

Year:  2015        PMID: 26553747     DOI: 10.1111/ane.12530

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  1 in total

1.  Raven coloured progressive matrices in migraine without aura patients.

Authors:  Giovanna Viticchi; Lorenzo Falsetti; Marco Bartolini; Laura Buratti; Lara Pistelli; Leandro Provinciali; Mauro Silvestrini
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.